Title |
The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole
|
---|---|
Published in |
Trials, June 2013
|
DOI | 10.1186/1745-6215-14-190 |
Pubmed ID | |
Authors |
Giovani Missio, Doris Hupfeld Moreno, Fernando Fernandes, Danielle Soares Bio, Márcio Gehardt Soeiro-de-Souza, Domingos Rodrigues dos Santos, Denise Petresco David, Luis Felipe Costa, Frederico Navas Demétrio, Ricardo Alberto Moreno |
Abstract |
The treatment of bipolar disorder (BD) remains a challenge due to the complexity of the disease. Current guidelines represent an effort to assist clinicians in routine practice but have several limitations, particularly concerning long-term treatment. The ARIQUELI (efficacy and tolerability of the combination of lithium or aripiprazole in young bipolar non or partial responders to quetiapine monotherapy) study aims to evaluate two different augmentation strategies for quetiapine nonresponders or partial responders in acute and maintenance phases of BD treatment. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 84 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 15 | 18% |
Student > Bachelor | 9 | 11% |
Student > Doctoral Student | 7 | 8% |
Student > Master | 7 | 8% |
Other | 6 | 7% |
Other | 17 | 20% |
Unknown | 23 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 25 | 30% |
Psychology | 11 | 13% |
Nursing and Health Professions | 6 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
Biochemistry, Genetics and Molecular Biology | 4 | 5% |
Other | 6 | 7% |
Unknown | 27 | 32% |